Search is Powered by Google
Medical Devices / Diagnostics News

Insights Into 'Blinking' Phenomena Could Improve Biological Imaging

Main Category: Medical Devices / Diagnostics
Also Included In: MRI / PET / Ultrasound;  HIV / AIDS;  Cancer / Oncology
Article Date: 02 Jul 2008 - 7:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
<A HREF="http://www.mlclick.com/mlcl.php?aid=B1F0C1D32D0A9D9782E1C424695C5C0C" target="_blank"><IMG SRC="http://www.mlclick.com/mltr.php?aid=B1F0C1D32D0A9D9782E1C424695C5C0C&b=2" WIDTH="300" HEIGHT="250" BORDER="0" alt="41st World Forum for Medicine, International Trade Fair with Congress"></A>


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

A new paper by a team of researchers led by University of Notre Dame physicist Bolizsar Janko provides an overview of research into one of the few remaining unsolved problems of quantum mechanics.

More than a century ago, at the dawn of modern quantum mechanics, the Nobel Prize-winning physicist Neils Bohr predicted so-called "quantum jumps." He predicted that these jumps would be due to electrons making transitions between discrete energy levels of individual atoms and molecules. Although controversial in Bohr's time, such quantum jumps were experimentally observed, and his prediction verified, in the 1980s. More recently, with the development of single molecule imaging techniques in the early 1990s, it has been possible to observe similar jumps in individual molecules.

Experimentally, these quantum jumps translate to discrete interruptions of the continuous emission from single molecules, revealing a phenomenon known as florescent intermittency or "blinking."

However, while certain instances of blinking can be directly ascribed to Bohr's original quantum jumps, many more cases exist where the observed fluorescence intermittency does not follow his predictions. Specifically, in systems as diverse as fluorescent proteins, single-light harvesting complexes, single organic fluorophores, and, most recently, individual inorganic nanostructures, clear deviations from Bohr's predictions occur.

As a consequence, virtually all know fluorophores, including fluorescent quantum dots and molecules, exhibit unexplainable episodes of intermittent "blinking" in their emission. The underlying quantum mechanical process responsible for this phenomenon is an enduring mystery in modern chemical physics.

In a paper appearing in today's edition of the journal Nature Physics, Jankó and his colleagues present a "progress report" on the research, including their own, that has been aimed at unlocking the mysteries of these fluorescent molecules or flourophores. They hope the paper will help spark further experimental and theoretical activity to solve the mystery of fluorescence intermittency.

Finding the answer could lead to powerful imaging probes that will enable future researchers to better track disease-related molecules within cells.

"Fluorescent molecules could be of fundamental importance in imaging biological systems and monitoring dynamic processes in vivo," Jankó said. "One of the most attractive types of flourophores today are semiconductor nanocrystal quantum dots (NQD). Their small size, brightness, photostability and highly tunable fluorescent color make them vastly superior to organic dyes."

The blinking phenomenon, however, presents a daunting difficulty in using these dots, especially for such applications as single-molecule biological imaging, where a single NQD is used as a fluorescent label.

"The NQD is fluorescent for some time, a so-called 'on-time,' and then becomes optically inactive, experiencing an 'off-time,' whereupon it turns on again," Jankó said.

If the blinking process could be controlled, quantum dots could, for example, provide better, more stable, multi-color imaging of cancer cells or provide researchers with real-time images of a viral infection, such HIV, within a cell.

"It is very important to elucidate the origin of this phenomenon and to identify ways to control the blinking process," Jankó said.

Jankó's Notre Dame research group already has taken a strong first step toward understanding the phenomenon through research by group member Masaru Kuno, an assistant professor of chemistry and biochemistry at the University. Kuno has discovered that the on- and off-time intervals of intermittent nanocrystal quantum dots follow a universal power law distribution. This discovery has provided Notre Dame researchers and others with the first hints for developing a deeper insight into the physical mechanism behind the vast range of on- and off-times in the intermittency.

Jankó has received a $1.2 million National Science Foundation Nanoscale Interdisciplinary Research Team (NIRT) grant to help solve the fluorescence intermittency mystery.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Source: Boldizsar Janko
University of Notre Dame




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA Approves KAPIDEX (dexlansoprazole) Delayed-Release Capsules For The Treatment Of GERD
03 Feb 2009
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved KAPIDEX™ (dexlansoprazole)...


Naps Aren't Just for Kids Anymore
Naps Aren't Just for Kids Anymore

A power nap may be the answer to the mid-day slump. Research suggests naps improve productivity, mental function, and motor function. They also may improve cardiovascular health.

more videos are available in our health videos section.